The announcement of a billion dollar settlement by Stryker of thousands of lawsuits involving its recalled all-metal hip implant devices will likely spur additional advertising by plaintiffs' law firms and others seeking additional claimants. Typically, mass tort advertisers increase their advertising efforts following the announcement of major settlements in an effort to attract potential claimants eligible for compensation. In the month following last November's announcement of a multi-billion dollar settlement by Johnson & Johnson to settle thousands of lawsuits related to its hip implant products, spending on mass tort TV advertising focused on hip implants topped $2.5 million -- an increase of over 50% from the previous month. Read full article.
Some prominent plaintiffs’ law firms are betting on the potential for future litigation with a stepped-up ad campaign targeting the cancer risk associated with the laparoscopic power morcellator gynecological surgical device. With an advertising push led by the New York firm Weitz & Luxenberg and Maryland attorney Peter Angelos, law firms spent over $1 million to air over 1,300 morcellator mass tort ads in August. The combined ad campaign cast a wide net for potential plaintiffs with over 60% of the ads airing on national broadcast and cable channels and other ads appearing on local stations across the country. Read full article.
Opening a new front in the mass tort litigation wars, plaintiffs’ attorneys launched an aggressive advertising campaign targeting the blood thinner drug Xarelto in July -- increasing their total monthly ad spending by nearly $1.2 million to air over 1,800 ads. The advertising blitz follows reports from earlier this summer that the blood thinner, sold by Johnson & Johnson in the United States and Bayer in Europe, was facing its first lawsuits in the US. Read full article.